Consulting expertise for pharmaceutical manufacturer in alleged False Claims Act case
Served as consulting expert to counsel for a pharmaceutical manufacturer alleged to have engaged in improper marketing practices, including off-label marketing and speaker programs, in violation of the False Claims Act. Supported counsel in analyzing causation and potential exposure based on trends in IQVIA prescribing data, third-party physician surveys, and Medicare and Medicaid prior authorization policies.